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ABSTRACT
The effect of fever was studied on the pharmacokinetics of ceftriaxone (CTRX) following intravenous 
administration at the rate of 50 mg/kg b.m. in Chhotanagpuri sheep. Fever was induced by intravenous 
administration of E. coli serovar O126:B8 lipopolysaccharide, and plasma CTRX concentration was estimated 
by HPLC. The plasma drug concentration versus time curve best fi tted a two compartment open model. The 
maximum plasma drug concentration was 16.33 per cent lower in febrile sheep (FS) in comparison to normal 
sheep (NS). In FS, t1/2α was lower, while t1/2β was higher than in NS. Vdarea and P: C ratio was higher in FS, 
but ClB and AUC did not differ signifi cantly between the two groups. The results of the present study indicate 
that CTRX has greater distribution in the peripheral compartment during pyrexia. High values of K12/K21 ratio 
also indicated rapid drug distribution in various body fl uids and compartments. The suitable dosage regimen of 
CTRX in FS by the intravenous route was calculated to be 15 mg/kg b.m. at a 5 h interval. 
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Introduction
Ceftriaxone (CTRX) is a third generation cephalosporin, which is used extensively 
in veterinary clinical practice, because of its broad spectrum antibacterial activity, low 
toxicity and resistance to β-lactamases produced by gram-positive as well as gram- 
negative bacteria (ANGEHRN et al., 1980; CLEELAND and SQUIRES et al., 1984). This drug 
has high potential application in septicemia/bacteremia, lower respiratory tract infection, 
urinary tract infection, peritonitis, enteritis and soft tissue infections, because of its 
excellent penetration into the extra vascular space (PATEL and KAPLAN, 1984; TAN et al., 
1984). 
For better response in clinical practice, knowledge of the pharmacokinetic-
pharmacodynamic parameters of a drug is essential. The pharmacokinetic profi le of 
CTRX varies with animal species, disease conditions and route of administration (DARDI 
and SHARMA, 2004; SAR et al., 2006; GOUDAH, 2008). Fever, one of the most common 
manifestations of many infectious diseases, is reported to change heart rate, renal blood 
fl ow, hepatic and splanchnic blood fl ow (KASTING et al., 1982). The pharmacokinetic 
profi le of many drugs changes during fever (WILSON et al., 1984; CHAUDHARY et 
al., 1999). There seems to be no recent report available on the effect of fever on the 
pharmacokinetics of ceftriaxone in sheep. Therefore, the present study was aimed to study 
the pharmacokinetics and recommend an optimal dose of ceftriaxone in febrile sheep. 
Materials and methods
The present study was conducted in female Chhotanagpuri sheep (n = 12), of 2 to 2.5 
years age and 13-15 kg body mass. Animals were housed in the departmental shed for 
30 days acclimatization. Animals were fed with a balanced ration, green fodder and fresh 
water was provided ad libitum. The experiment was conducted as per the guidelines of 
the Committee for the Purpose of Control and Supervision on Experiments on Animals, 
Government of India. 
Animals were randomly divided into two groups (n = 6 each), group I served as the 
afebrile normal sheep model (experiment I), while group II served as the febrile sheep 
model (experiment II). 
Experiment I 
Drug administration and sample collection. A single intravenous injection of CTRX 
(Injection WOCFF 3 g, Wockhardt Pvt. Ltd. Mumbai, India) at the rate of 50 mg/kg body 
mass was given to each experimental animal. Rectal temperature was recorded prior to 
drug administration and thereafter at hourly intervals. About 2 mL of blood sample was 
collected in separate heparinized vials by jugular venipuncture at an interval of 0.04, 0.08, 
0.16, 0.25, 0.33, 0.50, 0.75, 1, 2, 3, 4 and 6 hours after drug administration. Plasma was 
harvested and stored at -20 °C until drug assay.
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Drug assay. The concentrations of CTRX were estimated by high performance 
liquid chromatography (SAR et al., 2006). The chromatographic system, Cecil 4100 (Cecil 
Instrumentation, Cambridge) was used. The mobile phase consisted of acetonitrile and 
water (40:60) and tetraheptyl ammonium bromide (0.32 per cent) as an ion pairing agent. 
The concentration of CTRX was scanned at 280 nm wavelength. The limit of quantization 
was 1.56 μg/mL and mean (± SE) absolute recovery of CTRX was 118.23 ± 8.93 per cent. 
The intra-assay and inter-assay coeffi cients of variation in the present study were found to 
be 7.65.and 9.5 per cent respectively. 
Experiment II 
Induction of fever. Fever was induced by intravenous administration of E. coli 
serotype O126:B8 lipopolysaccharide (LPS) at the rate of 0.2 μg/kg body mass. After 
5 hours, half of the initial LPS dose was repeated intravenously for maintenance of the 
fever up to 12 hours.
Drug administration, sample collection and drug assay. A single dose of CTRX at the 
rate of 50 mg/kg body mass was injected intravenously after an hour of LPS administration. 
The rest of the procedures, including sample collection and drug assay, were similar to 
those followed in experiment I. 
Pharmacokinetic analysis. Various pharmacokinetic parameters were calculated as 
per the standard methods (BAGGOT, 1977; NOTARI, 1980). The intravenous dose rate (mg/
kg body mass) and dose interval (h) of CTRX in febrile sheep were calculated as per the 
formulae given by SHARGEL and ANDREW (1985).
Calculation of dosage regimen and P/C ratio. 
The dose and dosing interval of CTRX was calculated by the standard method 
(SHARGEL and ANDREW, 1985).
                   Cp max = (Dose/Vd) / 1-e 
-β.r
                             Cp max/ Cp min   = 1/e 
-β.r
Where, 
               r = interval for dose repeat, β = overall elimination rate constant 
P/C ratio = (K12/ K21
-β)
Statistical analysis. Different pharmacokinetic parameters and plasma drug 
concentrations at different observation periods were statistically analyzed using the 
Student t-test (SNEDECOR and COCHRAN, 1984). 
Results
In group I animals, rectal temperature varied within the normal range during the 
entire experimental period. In group II animals, a rise in rectal temperature (39.4 - 40.5 
426 Vet. arhiv 81 (4), 423-432, 2011
R. Ranjan et al.: Ceftriaxone pharmacokinetics and dosage regimen in febrile sheep
ºC) was observed one hour after the LPS administration, and it was maintained up to 12 
hours. 
Plasma CTRX concentration, as a function of time in normal (NS) and febrile sheep 
(FS) following its single intravenous administration, was plotted on a semi logarithmic 
scale (Fig. 1). Plasma drug concentration versus time profi le showed a biphasic 
disposition curve. The data was best fi tted to a bi-exponential equation according to a 
two-compartment open model. Plasma drug concentration (C0) in FS observed after 2.5 
minutes of drug administration was about 16.33 per cent lower than that of NS. A gradual 
decline in drug concentration occurred thereafter and fell below the detection limit after 
3 hours. Mean plasma drug concentration in NS remained signifi cantly (P<0.01) higher 
from corresponding levels in FS up to half an hour and thereafter, levels in NS were 
recorded signifi cantly (P<0.01) lower than corresponding levels in FS. 
Table 1. Pharmacokinetic profi le of ceftriaxone following its single intravenous administration (50 
mg/kg body mass) in healthy (n = 6) and febrile sheep (n = 6)
Pharmacokinetic 
parameter Normal sheep Febrile sheep t-value
A (μg/mL) 207.16 ± 12.15 257.84 ± 12.85 2.87*
B (μg/mL) 67.90 ± 1.91 43.16 ± 1.75 9.56**
C0p (μg/mL) 275.06 ± 10.65 301.00 ± 12.66 1.57NS
α (h-1) 11.79 ± 0.83 17.01 ± 0.36 5.79**
β (h-1) 1.17 ± 0.04 0.76 ± 0.03 7.99 NS
t½α (h) 0.06 ± 0.00 0.04 ± 0.00 5.40**
t½β (h) 0.60 ± 0.02 0.92 ± 0.03 8.00**
AUC (mg/L.h) 75.71 ± 1.66 72.26 ± 3.10 0.98 NS
MRT (h) 0.63 ± 0.03 1.04 ± 0.04 7.80**
ClB (mL/kg/min) 11.28 ± 0.24 11.49 ± 0.48 0.40
 NS
Vdarea(L/kg) 0.58 ± 0.01 0.91 ± 0.03 9.36**
K21 (h
-1) 3.77 ± 0.14 3.09 ± 0.12 3.76 NS
K12  (h
-1) 5.55 ± 0.59 10.50 ± 0.35 7.20**
Kel  (h
-1) 3.64 ± 0.18 4.17 ± 0.14 2.32*
P/C 1.97 ± 0.27 4.55 ± 0.30 6.40**
**P<0.01; *P<0.05; NS = Non-signifi cant
The pharmacokinetic parameters are summarized in Table 1. In febrile sheep, the 
half life of the distribution phase was lower, while the half life of the elimination phase 
was higher in comparison to NS (control). However, total body clearance of the drug 
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did not differ signifi cantly between the two groups. Also, no signifi cant difference was 
observed in the area under the plasma concentration curve (AUC) between the groups. 
The volume of distribution in the total area under curve was signifi cantly (P<0.01) higher 
in the febrile group. The peripheral/central compartment drug concentration ratio was 
signifi cantly (P<0.01) higher in FS.
The suitable dosage regimen for CTRX in FS was calculated to be 15 mg/kg body 
mass at 5 hour intervals.
Fig. 1. Semilogarithmic plot of plasma ceftriaxone (CTRX) concentration versus time in normal 
and febrile sheep after intravenous administration of CTRX 
Discussion
E. coli LPS is widely used to induce pyrexia in sheep and to study the effects of 
fever on the pharmacokinetic profi le of different drugs (WILSON et al., 1984; RULE et al., 
2000). When injected intravenously, it interacts with various cellular components of blood 
such as neutrophils, basophils, eosinophils, monocytes and other fi xed macrophages, 
resulting in the release of endogenous pyrogens and hence induces a febrile condition 
(DINARALLO, 1979). 
Evaluation of results indicated that the pharmacokinetics of CTRX after its 
intravenous administration in both NS and FS followed a two compartment open model. 
Following single intravenous CTRX administration, plasma drug concentration declined 
rapidly with time. Drug concentrations remained higher in NS in comparison to FS for up 
to half an hour, but the trend reversed thereafter. This may be correlated to temperature 
variation in pyrectic sheep. Following E. coli LPS administration, the temperature rises 
initially and then declines gradually. In comparison to normal animals, lower plasma drug 
concentration during pyrexia has been reported for CTRX in buffalo calves (DARDI et 
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gentamycin in goats (AHMAD et al., 1994), oxytetracycline in goats (MANNA et al., 1993) 
and cefuroxime in buffalo calves (CHAUDHARY et al., 1999). On the contrary, higher 
plasma levofl oxacin concentrations in febrile goats in comparison to normal animals 
were reported in the recent past (MISHRA, 2006). During fever, the kidneys show certain 
biochemical changes leading to impaired drug excretion. Reduced cardiac output further 
impairs the renal blood fl ow and hence renal drug excretion (BLATTEIS et al., 1988). This 
mechanism could be more pertinent for levofl oxacin, which is mainly excreted by the 
renal route. Decreased drug elimination during fever has also been reported for other 
drugs (SONG et al., 1972; TRENHOLME et al., 1976).
The normal pharmacokinetic profi le of CTRX has been studied in many animal 
species including cats (ALBARELLOS et al., 2007) goat (ISMAIL, 2005), camel (GOUDAH, 
2008) and dogs (REBUELTO et al., 2002). In all these studies, drug disposition kinetics after 
intravenous administration best fi tted a two compartment open model. 
Many pharmacokinetic parameters (apparent volume of distribution and rate constants 
of distribution phases) of CTRX during pyrexia have been reported to differ from that 
observed in normal buffalo calves following single intravenous CTRX administration 
(DARDI et al., 2005). However, there seems to be no report available on changes in CTRX 
pharmacokinetics in sheep during pyrexia. It is well established that the kinetics of 
many antibiotics including cephalosporines (ACHARYA et al., 1994; DARDI et al., 2005), 
aminoglycosides (TARDIF et al., 1990) and fl uoroquinolones (WAXMAN et al., 2003) 
changes during fever induced by E. coli LPS administration. 
The t½β in FS was higher than that observed in NS. Likewise, a higher value of t½β was 
reported in febrile goats following intravenous administration of CTRX (SINGH et al., 2004). 
Higher t½β in febrile animals can be attributed to the effects of endotoxin on the normal 
physiology. Endotoxin causes hepatic and renal dysfunctions (WILKINSON et al., 1974) 
along with haemodynamic depression (VAN MIERT, 1973). The haemodynamic depression 
may be responsible for slower drug elimination in febrile animals; while alterations in 
hepatic function may cause lower normal drug metabolism and transformation. 
The high values of distribution rate, constant in FS as well as NS, indicated that 
CTRX was rapidly distributed into various body fl uid and tissue compartments. The rapid 
distribution of CTRX was further substantiated by high values of K12/K21 ratio in buffalo 
calves (DARDI et al., 2005). Similar observations were reported in febrile calves following 
intravenous administration of enrofl oxacin (AHANGAR and SRIVASTAVA, 2000) and 
cephaloridine (SINGH et al., 1997). 
Signifi cantly higher values of AUC for cefepime in healthy buffalo calves in 
comparison to febrile animals have been reported in the past (PAWAR and SHARMA, 2008). 
Likewise, DARDI et al. (2005) also reported higher AUC for CTRX in healthy buffalo 
calves in comparison to those observed in febrile animals. However, in the present study 
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the values of AUC did not differ signifi cantly between the two groups, although it was 
numerically higher in NS. It has been suggested that low urine fl ow and a shift to a more 
acidic pH favour possible tubular reabsorption of lipophilic weak acids (VAN MIERT, 
1990). A reduction in pH of urine has been reported during fever in goats (VAN GOGH 
et al., 1989), which may explain the possible cause of a reduction in AUC during fever, 
observed in the present study and in other reports. 
Higher values of Vdarea in FS in comparison to NS indicated that CTRX was more 
extensively distributed in various body fl uids and tissues in FS. It occurred perhaps due 
to the increased capillary permeability caused by different chemical mediators released 
during the fever (YANG and LEE, 2008). Hyperthermia causes alterations in renal function 
(MUSTAFA et al., 2007). Tachycardia and increased total cardiac output may be the 
possible reasons behind the increased renal perfusion and glomerular fi ltration (RULE et 
al., 2000).
In accordance to our present fi ndings, PAWAR and SHARMA (2008) also observed 
higher values of Vdarea in febrile buffalo calves in comparison to healthy ones after 
intravenous administration of cefepime. Higher values of Vdarea in febrile animals have 
also been reported for other antibiotics such as oxytetracycline (SINGH et al., 1998), 
cefuroxime (CHAUDHARY et al., 1999) and cefotaxime (SHARMA et al., 2006). 
The P/C ratio observed in this study indicated a high distribution of drug to tissues 
(AHANGAR and SRIVASTAVA, 2000). The higher P/C ratio in FS indicated that the drug 
has greater distribution in peripheral compartment during pyrexia. The high value of the 
K12/K21 ratio also substantiated the rapid distribution of CTRX into various body fl uids 
and tissue compartments (DARDI et al., 2005).
Calculation of a suitable dosage regimen of CTRX in febrile sheep on the basis of 
pharmacokinetic parameters was the ultimate objective of the present study. A minimum 
therapeutic plasma CTRX concentration of 1.0 μg/mL has been shown to be the most 
effective against the majority of sensitive Gram-positive and Gram-negative pathogens 
(PERRY and SCHENTAG, 2001). Intravenous administration of CTRX 15 mg/kg at 5 h 
interval appeared to be the suitable dosage regimen in febrile sheep. This dose is slightly 
less that the dosage of CTRX recommended in febrile buffalo calves (DARDI et al., 
2005).
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SAŽETAK
Istraživan je učinak vrućice na farmakokinetiku  ceftriaksona (CTRX)  nakon njegove intravenske primjene 
u dozi od  50 mg/kg tjelesne mase u ovaca pasmine Chhotanagpuri.  Vrućica je bila uzrokovana intravenskom 
primjenom lipopolisaharida serovara O126:B8 bakterije E. coli. Koncentracija cefriaksona u plazmi bila je 
određivana visokotlačnom tekućinskom kromatografi jom. Koncentracija lijeka u plazmi u odnosu na vremensku 
krivulju bila je najsličnija modelu dvaju odjeljaka. Najveća koncentracija lijeka bila je 16,33% manja u febrilnih 
ovaca u odnosu na nefebrilne. U febrilnih je ovaca t1/2α bio manji, a t1/2β veći nego u nefebrilnih. Prividni 
volumen raspodjele (Vdarea) i omjer P:C bili su veći u febrilnih ovaca dok se ClB (ukupni klirens lijeka iz 
organizma) i AUC (površina ispod koncentracijske krivulje lijeka u plazmi) nisu značajno razlikovali između 
dviju skupina. Rezultati ovog istraživanja naznačuju da ceftriakson ima bolju raspodjelu u perifernom odjeljku 
za vrijeme vrućice. Velike vrijednosti odnosa K12/K21 također upućuju na brzu raspodjelu lijeka u različitim 
tjelesnim tekućinama i odjeljcima. Izračunato je da je ceftriakson u febrilnih ovaca najbolje davati intravenski 
u dozi od 15 mg/kg tjelesne mase u razmaku od pet sati.
Ključne riječi: ceftriakson, E. coli, endotoksin, farmakokinetika, vrućica, ovce
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